A retrospective analysis of serum CA 15-3 concentrations in patients with localised or metastatic renal cancer and its impact on prognosis and follow-up. A single-centre experience

UroOncology

Volumn 2, Issue 4, 2002, Pages 179-184

  Briasoulis, E ^a   Pentheroudakis, G ^a   Letsa, I ^a   Pavlidis, N ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

CA 15 3; Pulmonary metastases; Renal cancer; Tumor markers

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BIOPSY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CANCER; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; METASTASIS; NEPHRECTOMY; PATIENT MONITORING; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; VALIDATION PROCESS;

EID: 0036970870     PISSN: 15610950     EISSN: None     Source Type: Journal    
DOI: 10.1080/1561095021000064299     Document Type: Article

References (17)

1. Godley, P.A. and Ataga, K.I. (2000) "Renal cell carcinoma", Curr. Opin. Oncol. 12(3), 260-264.
2. Motzer, R.J., Bander, N.H. and Nanus, D.M. (1996) "Renal-cell carcinoma", N. Engl. J. Med. 335(12), 865-875.
3. Motzer, R.J., Mazumdar, M., Bacik, J., Berg, W., Amsterdam, A. and Ferrara, J. (1999) "Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma", J. Clin. Oncol. 17(8), 2530.
4. Bombardieri, E., Pizzichetta, M., Veronesi, P., Seregni, E., Bogni, A., Maffioli, L., et al. (1992) "CA 15.3 determination in patients with breast cancer: clinical utility for the detection of distant metastases", Eur. J. Cancer 29A(1), 144-146.
5. Hayes, D.F., Zurawski, Jr., V.R. and Kufe, D.W. (1986) "Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer", J. Clin. Oncol. 4(10), 1542-1550.
6. Nakamura, T., Hayama, M. and Shimada, M. (1995) "Expression of CA15-3 in renal cell carcinoma [letter]", Pathol. Int. 45(10), 787-789.
7. Masuda, H., Kurita, Y., Suzuki, A., Kanbayashi, T., Suzuki, K. and Fujita, K. (1997) "Prognostic factors for renal cell carcinoma: a multivariate analysis of 320 cases", Int. J. Urol. 4(3), 247-253.
8. Grankvist, K., Ljungberg, B. and Rasmuson, T. (1997) "Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma", Int. J. Cancer 74(2), 233-236.
9. Huber, P.R., Bischof, P., Kretschmer, R., Truschnig, M., Halwachs, G. and Schmidt, M. (1996) "CA 15-3: a multicentre evaluation of automated and manual tests", Eur. J. Clin. Chem. Clin. Biochem. 34(1), 77-84.
10. McLaughlin, J.K., Mandel, J.S., Blot, W.J., Schuman, L.M., Mehl, E.S. and Fraumeni, Jr., J.F. (1984) "A population - based case - control study of renal cell carcinoma", J. Natl Cancer Inst. 72(2), 275-284.
11. Levy, D.A., Swanson, D.A., Slaton, J.W., Ellerhorst, J. and Dinney, C.P. (1998) "Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinoma", J. Urol. 159(4), 1168-1173.
12. Colomer, R., Ruibal, A., Navarro, M., Encabo, G., Sole, L.A. and Salvador, L. (1986) "Circulating CA 15-3 levels in breast cancer. Our present experience", Int. J. Biol. Markers 1(2), 89-92.
13. Colomer, R., Ruibal, A. and Salvador, L. (1989) "Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease", Cancer 64(8), 1674-1681.
14. Levy, D.A., Swanson, D.A., Slaton, J.W., Ellerhorst, J. and Dinney, C.P. (1998) "Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinoma", J. Urol. 159(4), 1168-1173.
15. Fujita, K., Denda, K., Yamamoto, M., Matsumoto, T., Fujime, M. and Irimura, T. (1999) "Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients", Br J. Cancer 80(1-2), 301-308.
16. Kraus, S., Abel, P.D., Nachtmann, C., Linsenmann, H.J., Weidner, W., Stamp, G.W., et al. (2002) "MUC1 mucin and trefoil factor 1 protein expression in renal cell carcinoma: correlation with prognosis", Hum. Pathol. 33(1), 60-67.
17. Pandey, P., Kharbanda, S. and Kufe, D. (1995) "Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein", Cancer Res. 55(18), 4000-4003.